We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Petition Asks FDA to Halt Competing MS Drug Approvals
Teva Petition Asks FDA to Halt Competing MS Drug Approvals
January 18, 2013
Teva Pharmaceuticals has filed yet another citizen petition to protect its exclusivity on Copaxone and delay competitors submitting multiple sclerosis (MS) drugs.